Follow us Facebook Icon


17 December 2021

World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine 'COVOVAX™'

World Health Organization (WHO) has granted Emergency Use Listing (EUL) for NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine 'COVOVAX™' with Matrix-M™ adjuvant, for active immunization of individuals 18 years of age and older for the prevention of coronavirus disease 2019 caused by SARS-CoV-2...Read more...

26 November, 2021

Serum Institute of India (SII) re-starts COVAX exports; passes 1 billion COVISHIELD dose milestone

Serum Institute of India (SII) today announces it has resumed exports to the international vaccine sharing programme COVAX...Read more...

Cyrus Poonawalla

Dr. Cyrus S. Poonawalla

Chairman and Managing Director
Mr. Adar C. Poonawalla

Mr. Adar C. Poonawalla

Natasha Poonawalla

Mrs. Natasha A. Poonawalla

Executive Director - Serum Institute of India
Chairperson - Villoo Poonawalla Foundation


Poonawalla Group

The Cyrus Poonawalla Group of Companies headquartered in Pune, India are a diversified group with business interests that include Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty and Aviation.